The Business Research Company published its Influenza Diagnostic Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Influenza Diagnostic market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.
The report covers the influenza diagnostic market’s segments-
1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Others
2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests
3) By End User: Hospitals & Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users.
View Complete Report: https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-market-global-report-2020-30-covid-19-implications-and-growth
Influenza Diagnostic Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
The global influenza diagnostics market is expected to grow from $1.14 billion in 2019 to 1.31 billion in 2020 at a compound annual growth rate (CAGR) of 14.7%. A significant increase is registered in 2020 due to the COVID 19 outbreak. The global pandemic which is expected to be there for some time and the upcoming flu season could place a tremendous burden on the healthcare system and result in many illnesses, hospitalizations and deaths. This is expected to drive the demand for more rapid detection diagnostic kits. Since COVID-19 and the flu are respiratory illnesses and can cause similar symptoms, the governments across the globe are making preparedness plans. For instance, the CDC is seeking emergency use authorization from the FDA for a new assay that can simultaneously detect SARS-CoV-2 and influenza. The market is then expected to stabilize and reach $1.43 billion in 2023 at a CAGR of 2.89%.
Rapid influenza diagnostic tests (RIDTs) are increasingly being implemented in influenza diagnostics. RIDTs are immunoassays which can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and display the result in a qualitative way (positive vs. negative). It can yield results in a clinically relevant time frame of less than approximately 15 minutes and diagnose patients, who are present with influenza-like illness, mainly if it is performed within the first four days of the onset of symptoms.
Few Points From Table Of Content
1. Executive Summary
2. Influenza Diagnostics Market Characteristics
3. Influenza Diagnostics Market Size And Growth
4. Influenza Diagnostics Market Segmentation
5. Influenza Diagnostics Market Regional And Country Analysis
……
25. Influenza Diagnostics Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Influenza Diagnostics Market
27. Influenza Diagnostics Market Trends And Strategies
28. Influenza Diagnostics Market Future Outlook and Potential Analysis
29. Appendix
Request For A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp
Few Points From List Of Table
Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 3: Global Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
……..
Table 48: ?h?rm? F??h?r Financial Performance
Table 49: Abbott Laboratories Financial Performance
Table 50: Hologic Financial Performance
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
The Business Research Company’s latest report Influenza Diagnostic Global Market Report 2020 covers Influenza Diagnostic market drivers, Influenza Diagnostic market trends, Influenza Diagnostic market segments, Influenza Diagnostic market growth rate, Influenza Diagnostic market major players, and Influenza Diagnostic market size.
The report provides in-depth analysis of the impact of COVID-19 on the Influenza Diagnostic industry, along with revised market numbers due to the effects of the coronavirus.View Complete Report: https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-market-global-report-2020-30-covid-19-implications-and-growthInfluenza Diagnostic Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.Request For The Sample Now: https://www.thebusinessresearchcompany.com/sample.aspx?id=3237=smpThe global influenza diagnostics market is expected to grow from $1.14 billion in 2019 to 1.31 billion in 2020 at a compound annual growth rate (CAGR) of 14.7%.
The global pandemic which is expected to be there for some time and the upcoming flu season could place a tremendous burden on the healthcare system and result in many illnesses, hospitalizations and deaths.
This is expected to drive the demand for more rapid detection diagnostic kits.
The global Digital Rapid Influenza Diagnostic Test Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Digital Rapid Influenza Diagnostic Test Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/digital-rapid-influenza-diagnostic-test-market/download-sampleMarket DynamicsInfluenza viruses being responsible for the winter epidemics of respiratory illness among all age groups will be the primary trending factor for market growth.
These digital testing platforms eliminating the need for an operator to visualize and interpret test results will be a market booster.
These RIDTs with enhanced sensitivity of detection for the seasonal, novel, and variant influenza strains and meeting the FDA's criteria should expand appropriate patient management opportunities.
The possibility of false-positive results is the main hindrance to the growth of the market.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
